Biodegradable hollow fibres for the controlled release of hormones

Journal of Controlled Release

Volumn 6, Issue 1, 1987, Pages 225-247

  Eenink, M J D ^a   Feijen, J ^a   Olijslager, J ^b   Albers, J H M ^b   Rieke, J C ^b   Greidanus, P J ^b  

^a UNIVERSITY OF TWENTE   (Netherlands)

^b TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

NORGESTREL H 3; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; DRUG RELEASE; FEMALE; IN VITRO STUDY; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0023608166     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-3659(87)90079-4     Document Type: Article

References (69)

1. Biodegradable systems for the sustained release of fertility-regulating agents
2. The design of controlled drug delivery systems based on biodegradable polymer
3. Biodegradable drug delivery systems
4. Biodegradable polymers for parenteral administration
5. Biodegradable implants: alternative approaches
6. Biodegradable polymers in controlled drug delivery
7. Biopolymer system design for sustained release of biologically active agents
8. Biodegradable delivery systems
9. Polymeric drug delivery systems
10. Chemical and Physical structure of polymers as carriers for controlled release of bioactive agents a review
11. Fundamentals of controlled-release drug administration
12. Polymeric inserts and implants for the controlled release of drugs
13. Membrane-controlled reservoir drug delivery systems
14. Controlled release of a luteinizing hormone-releasing hormone analogue from poly(d,l-lactide-co-glycolide) microspheres
15. Preparation and in vitro degradation properties of polylactide microcapsules
16. Microencapsulation of contraceptive steroids
17. Biodegradable, implantable sustained release systems based on glutamic acid copolymers
18. Controlled release of macromolecules and pharmaceuticals from synthetic polypeptides based on glutamic acid
19. The effect of a biodegradable contraceptive capsule (capronor) containing levonorgestrel on gonadotropin, estrogen, and progesterone levels
20. Capronor — a biodegradable delivery system for levonorgestrel
21. Fibrous polymers for the delivery of contraceptive steroids to the female reproductive tract
22. Biodegradable and nonbiodegradable fibrous delivery systems
23. Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios
24. Biodegradable polymers for use in surgery — poly (glycolic)/poly (lactic acid) homo and copolymers. 2. in vitro degradation
25. Bioresorbable plastic materials for bone surgery
26. Poly (lactic acid) and poly (lactic acid-co-glycolic acid) contraceptive delivery systems
27. Thermal oxidative degradation of poly-lactic acid
28. Thermal oxidative degradation of poly-lactic acid
29. Biocompatible poly-l-lactide fibers
30. Degradation studies of some polyesters and polycarbonates part 1 and 2: polylactide
31. Degradation studies of some polyesters and polycarbonates part 1 and 2: polylactide
32. Development and evaluation of a biodegradable drug delivery system
33. Sustained drug delivery systems II: factors affecting release rates from poly (ϵ-caprolactone) and related biodegradable polyesters
34. Biodegradable cylindrical implants for fertility control
35. In vitro and in vivo release of levonorgestrel from poly(ortho esters) I. Linear polymers; II. crosslinked polymers
36. In vitro and in vivo release of levonorgestrel from poly(ortho esters) I. Linear polymers; II. crosslinked polymers
37. Poly(lactide-co-glycolide) microcapsules for controlled release of steroids
38. Clinical evaluation of an improved injectable microcapsule contraceptive system
39. Polymeric delivery systems for controlled drug release
40. Synthesis of biodegradable polymers and development of biodegradable hollow fibres for the controlled release of drugs
41. Gel permeation chromatography XII. Computer-assisted gel permeation chromatography and low-angle laser light-scattering photometry
42. Gel permeation chromatography X. Molecular weight detection by low-angle laser light scattering
43. Investigation of the structure of solution grown crystals of lactide copolymers by means of chemical reactions
44. Sustained release hormonal preparations 2. Factors controlling the diffusion of steroids through dimethylpolysiloxane membranes
45. Stereoregular bioresorbable polyesters for orthopaedic surgery
46. Biodegradable polymers for use in surgery polyglycolic/poly (lactic acid) homo- and copolymers: 1
47. Polymers of N-vinylpyrrolidone synthesis characterization and uses
48. Hollow-fiber membranes
49. Polysulfone hollow fibers. II. Morphology
50. Membrane formation: diffusion induced demixing processes in ternary polymeric systems
51. Demixing and gelation behavior of ternary cellulose acetate solutions
52. Formation of membranes by means of immersion precipitation. A model to describe the mass transfer during immersion precipitation
53. Formation of membranes by means of immersion precipitation. The mechanism of formation of membranes prepared from the system cellulose acetate-acetone-water
54. Polysulfone hollow fibers. I. Spinning and properties
55. Polysulfone hollow fibers — effect of spinning conditions on ultrafiltration properties
56. Stability constants and thermodynamic parameters of some intramacromolecular complexes of acrylic copolymers and poly (vinyl pyrrolidone)
57. The antigenicity of poly (vinyl pyrrolidone) I
58. Polymere Hilfstoffe in der pharmaceutischen Technologie
59. Results on biodegradable cylindrical subdermals implants for fertility control
60. Progestin permeation through polymer membranes IV: Mechanism of steroid permeation and functional group contributions to diffusion through hydrogel films
61. Steroid release from silastic capsules and rods
62. Discussion: Polymeric delivery systems for contraception
63. In vivo fate of bioresorbable bone plates of long-lasting poly (l-lactic acid)
64. Biodegradation of polymers